Clinical Practice Guideline: Otitis Media with Effusion (Update)

Otolaryngology - Head and Neck Surgery - Tập 154 Số S1 - 2016
Richard M. Rosenfeld1, Jennifer J. Shin2, Seth Schwartz3, Robyn Coggins4, Lisa Gagnon5, Jesse M. Hackell6, David Hoelting7, Lisa L. Hunter8, Ann W. Kummer9, Spencer C. Payne9, Dennis S. Poe10, Maria C. Veling11, Peter M. Vila12, Sandra A. Walsh13, Maureen D. Corrigan14
1Department of Otolaryngology, SUNY Downstate Medical Center, Brooklyn, New York, USA
2Division of Otolaryngology, Harvard Medical School, Boston, Massachusetts, USA
3Department of Otolaryngology, Virginia Mason Medical Center, Seattle, Washington, USA
4Society for Middle Ear Disease, Pittsburgh, Pennsylvania, USA
5Connecticut Pediatric Otolaryngology, Madison, Connecticut, USA
6Pomona Pediatrics Pomona New York USA
7American Academy of Family Physicians, Pender, Nebraska, USA
8Cincinnati Children's Hospital Medical center, Cincinnati, Ohio USA
9University of Virginia Health System, Charlottesville, Virginia, USA
10Department of Otology and Laryngology Harvard Medical School and Boston Children’s Hospital Boston Massachusetts USA
11University of Texas–Southwestern Medical Center/Children’s Medical Center–Dallas Dallas Texas USA
12Department of Otolaryngology–Head and Neck Surgery Washington University School of Medicine in St Louis St Louis Missouri USA
13Consumers United for Evidence-Based Healthcare, Davis, California, USA
14American Academy of Otolaryngology—Head and Neck Surgery Foundation Alexandria Virginia USA

Tóm tắt

Objective

This update of a 2004 guideline codeveloped by the American Academy of Otolaryngology—Head and Neck Surgery Foundation, the American Academy of Pediatrics, and the American Academy of Family Physicians, provides evidence‐based recommendations to manage otitis media with effusion (OME), defined as the presence of fluid in the middle ear without signs or symptoms of acute ear infection. Changes from the prior guideline include consumer advocates added to the update group, evidence from 4 new clinical practice guidelines, 20 new systematic reviews, and 49 randomized control trials, enhanced emphasis on patient education and shared decision making, a new algorithm to clarify action statement relationships, and new and expanded recommendations for the diagnosis and management of OME.

Purpose

The purpose of this multidisciplinary guideline is to identify quality improvement opportunities in managing OME and to create explicit and actionable recommendations to implement these opportunities in clinical practice. Specifically, the goals are to improve diagnostic accuracy, identify children who are most susceptible to developmental sequelae from OME, and educate clinicians and patients regarding the favorable natural history of most OME and the clinical benefits for medical therapy (eg, steroids, antihistamines, decongestants). Additional goals relate to OME surveillance, hearing and language evaluation, and management of OME detected by newborn screening. The target patient for the guideline is a child aged 2 months through 12 years with OME, with or without developmental disabilities or underlying conditions that predispose to OME and its sequelae. The guideline is intended for all clinicians who are likely to diagnose and manage children with OME, and it applies to any setting in which OME would be identified, monitored, or managed. This guideline, however, does not apply to patients <2 months or >12 years old.

Action Statements

The update group made strong recommendations that clinicians (1) should document the presence of middle ear effusion with pneumatic otoscopy when diagnosing OME in a child; (2) should perform pneumatic otoscopy to assess for OME in a child with otalgia, hearing loss, or both; (3) should obtain tympanometry in children with suspected OME for whom the diagnosis is uncertain after performing (or attempting) pneumatic otoscopy; (4) should manage the child with OME who is not at risk with watchful waiting for 3 months from the date of effusion onset (if known) or 3 months from the date of diagnosis (if onset is unknown); (5) should recommend against using intranasal or systemic steroids for treating OME; (6) should recommend against using systemic antibiotics for treating OME; and (7) should recommend against using antihistamines, decongestants, or both for treating OME.

The update group made recommendations that clinicians (1) should document in the medical record counseling of parents of infants with OME who fail a newborn screening regarding the importance of follow‐up to ensure that hearing is normal when OME resolves and to exclude an underlying sensorineural hearing loss; (2) should determine if a child with OME is at increased risk for speech, language, or learning problems from middle ear effusion because of baseline sensory, physical, cognitive, or behavioral factors; (3) should evaluate at‐risk children for OME at the time of diagnosis of an at‐risk condition and at 12 to 18 months of age (if diagnosed as being at risk prior to this time); (4) should not routinely screen children for OME who are not at risk and do not have symptoms that may be attributable to OME, such as hearing difficulties, balance (vestibular) problems, poor school performance, behavioral problems, or ear discomfort; (5) should educate children with OME and their families regarding the natural history of OME, need for follow‐up, and the possible sequelae; (6) should obtain an age‐appropriate hearing test if OME persists for 3 months or longer OR for OME of any duration in an at‐risk child; (7) should counsel families of children with bilateral OME and documented hearing loss about the potential impact on speech and language development; (8) should reevaluate, at 3‐ to 6‐month intervals, children with chronic OME until the effusion is no longer present, significant hearing loss is identified, or structural abnormalities of the eardrum or middle ear are suspected; (9) should recommend tympanostomy tubes when surgery is performed for OME in a child <4 years old; adenoidectomy should not be performed unless a distinct indication exists (nasal obstruction, chronic adenoiditis); (10) should recommend tympanostomy tubes, adenoidectomy, or both when surgery is performed for OME in a child ≥4 years old; and (11) should document resolution of OME, improved hearing, or improved quality of life when managing a child with OME.

Từ khóa


Tài liệu tham khảo

10.1016/j.otohns.2004.02.002

Stool SE, 1994, Otitis Media with Effusion in Young Children: Clinical Practice Guideline No. 12

Berkman ND, 2013, Otitis Media with Effusion: Comparative Effectiveness of Treatments. Comparative Effectiveness Review No. 101

Rosenfeld RM, 2005, A Parent’s Guide to Ear Tubes

Tos M, 1984, Epidemiology and natural history of secretory otitis, Am J Otol, 5, 459

10.1016/j.ijporl.2007.12.008

Shekelle P, 2003, Diagnosis, Natural History and Late Effects of Otitis Media with Effusion: Evidence Report/Technology Assessment No. 55

10.1542/peds.2012-3488

10.1542/peds.99.3.318

Casselbrant ML, Evidence‐Based Otitis Media, 147

10.1007/s00405-009-1131-4

10.1016/j.ijporl.2009.07.015

10.1007/s00431-014-2323-5

10.1017/S0022215100128567

Williamson I, 2002, Otitis media with effusion, Clin Evid, 7, 469

10.1097/00005537-200310000-00004

10.1177/0194599813487302

10.1016/S0140-6736(89)91317-2

10.1288/00005537-198504000-00011

10.1177/147323001103900320

10.1016/j.amjoto.2010.08.002

10.1542/peds.2012-1988

10.1016/j.ijporl.2009.09.006

10.1017/S002221510013868X

10.1186/1471-2431-5-27

10.1016/j.ijporl.2012.03.027

10.1016/j.ijporl.2012.02.031

10.1542/peds.2009-3569

Qureishi A, 2014, Update on otitis media: prevention and treatment, Infect Drug Resist, 7, 15

10.1371/journal.pone.0036226

Bellussi L, 2005, Quality of life and psycho‐social development in children with otitis media with effusion, Acta Otorhinolaryngol Ital, 25, 359

10.1542/peds.83.4.477

10.1016/j.ijporl.2010.10.032

10.1016/S0264-410X(00)00271-1

10.1016/j.ijporl.2005.03.013

10.1017/S002221510014157X

10.1016/j.vaccine.2008.11.005

10.1001/archotol.129.9.987

10.1177/000348949510400806

10.1177/000348949810700507

10.1016/S0194-5998(98)70039-7

10.1542/peds.99.3.334

10.1001/archotol.1995.01890040056009

10.1001/archoto.2007.3

10.1001/archotol.126.5.585

10.1177/0194599812467425

10.1016/j.ijporl.2013.05.027

10.1001/jamapediatrics.2013.3924

10.1542/peds.2008-1482

10.1542/peds.2007-0619

Schwartz SR, 2003, Evidence‐Based Otitis Media

10.1001/archotol.125.1.12

Kong K, 2009, Natural history, definitions, risk factors and burden of otitis media, Med J Aust, 191, S39

Access‐Economics.The cost burden of otitis media in Australia2009.http://www.accesseconomics.com.au/publicationsreports/getreport.php?report=190&id=244. Accessed September 2009.

Zon A, 2012, Antibiotics for otitis media with effusion in children, Cochrane Database Syst Rev, 9, CD009163

10.1177/0194599811430809

10.1046/j.0905-6157.2000.00008.x

10.1046/j.1365-2222.1998.00284.x

10.1016/j.otc.2007.11.004

Griffin G, 2011, Antihistamines and/or decongestants for otitis media with effusion (OME) in children, Cochrane Database Syst Rev, 9, CD003423

Simpson SA, 2007, Identification of children in the first four years of life for early treatment for otitis media with effusion, Cochrane Database Syst Rev, 1

10.1177/0194599812467004

10.1136/amiajnl-2011-000172

10.1186/1472-6947-5-23

10.1001/jama.1992.03490010138042

10.1542/peds.2004-1260

10.1001/jama.287.5.612

10.1503/cmaj.061181

US Department of Health and Human Services.2012 annual progress report to congress: national strategy for quality improvement in health care.http://www.ahrq.gov/workingforquality/nqs/nqs2012annlrpt.pdf. PublishedMay 2014. Accessed August 8 2015.

10.1542/peds.112.3.510

10.1542/peds.109.3.404

10.1001/archpedi.155.10.1137

Onusko E, 2004, Tympanometry, Am Fam Physician, 70, 1713

American Speech‐Language‐Hearing Association, 1997, Guidelines for Audiologic Screening, 15

10.1542/peds.112.6.1379

10.1097/00003446-199408000-00005

10.1542/peds.58.2.198

10.1016/S0022-3476(86)80218-9

10.1097/AUD.0b013e31829d5158

10.1542/peds.2007-2333

10.1080/14992020600690951

10.1016/j.amjoto.2008.11.008

10.1097/00000446-200211000-00031

Calderon R, 1999, Further support of the benefits of early identification and intervention with children with hearing loss, Volta Rev, 100, 53

10.1056/NEJMoa054915

10.1097/MAO.0b013e31821b0d07

10.1016/j.ijporl.2004.11.006

National Institutes of Health, 1993, Early identification of hearing impairment in infants and young children, NIH Consens Statement, 11, 1

10.1044/1059-0889(2012/12-0016)

10.1542/peds.2006-1008

10.1097/00003446-199602000-00007

10.1097/00003446-200010000-00010

10.1542/peds.79.2.206

10.1097/00003446-200004000-00006

10.1097/MLG.0b013e31816d726c

10.1177/0194599811419468

10.1002/lary.1978.88.7.1139

10.1002/lary.5541030402

Ruben R, 2003, Evidence‐Based Otitis Media, 505

10.1542/peds.113.2.274

Gravel JS, Evidence‐Based Otitis Media, 342

10.1016/S0165-5876(99)00117-2

10.1111/j.1469-8749.1993.tb11681.x

Raut P, 2011, High prevalence of hearing loss in Down syndrome at first year of life, Ann Acad Med Singapore, 40, 493, 10.47102/annals-acadmedsg.V40N11p493

10.1177/0194599811425156

10.1002/ajmg.c.30095

10.1542/peds.2011-1605

Vanderas AP, 1987, Incidence of cleft lip, cleft palate, and cleft lip and palate among races: a review, Cleft Palate J, 24, 216

10.1046/j.1365-2273.2002.00607.x

10.1542/peds.2014-0323

D’Mello J, 2007, Audiological findings in cleft palate patients attending speech camp, Indian J Med Res, 125, 777

10.1597/07-219.1

McLaughlin MR, 2011, Speech and language delay in children, Am Fam Physician, 83, 1183

10.1097/00003446-198602000-00004

10.1097/00003446-199810000-00001

Simpson SA, 2007, Identification of children in the first four years of life for early treatment for otitis media with effusion, Cochrane Database Syst Rev, 1

10.1056/NEJM200104193441601

10.1046/j.1365-2273.1999.00259.x

10.1016/0165-5876(81)90027-6

10.1177/000348948309200215

10.3109/01050398009076330

Tos M, 1981, Changes in prevalence of secretory otitis from summer to winter in four‐year‐old children, Am J Otol, 2, 324

10.3109/00016488109133288

10.1542/peds.2005-0486

10.1371/journal.pone.0111732

10.1001/archotol.130.3.273

10.1016/j.ijporl.2003.09.002

Balen FA, 2000, Persistent otitis media with effusion: can it be predicted? A family practice follow‐up study in children aged 6 months to 6 years, J Fam Pract, 49, 605

10.1542/peds.106.4.725

10.1542/peds.113.3.e238

10.1542/peds.2008-3422

10.1542/peds.106.3.483

10.1016/S0022-3476(95)90249-X

10.1016/S0165-5876(00)00330-X

10.1159/000358549

10.1177/00034894800890S304

10.1111/j.1365-2273.1981.tb01781.x

10.1136/bmj.303.6802.558

10.1002/14651858.CD001935.pub2

10.3310/hta13370

10.1016/j.amjoto.2014.06.006

10.1016/j.ijporl.2005.08.013

10.1111/j.1399-3038.2010.01130.x

Schoem SR, 2010, A prospective, randomized, placebo‐controlled, double‐blind study of montelukast’s effect on persistent middle ear effusion, Ear Nose Throat J, 89, 434

10.3109/00016489.2013.824113

10.1177/00034894941030S516

10.1097/01.AUD.0000051988.23117.91

10.1097/01.aud.0000224727.45342.e9

10.1097/00003446-199602000-00001

10.1044/jslhr.4301.100

10.1001/archotol.130.5.524

10.1053/hn.1999.v121.a101041

10.1177/0194599814529080

10.1542/peds.2009-1997

American Speech‐Language‐Hearing Association.Typical speech and language development.http://www.asha.org/public/speech/development/. Accessed March 24 2015.

10.1016/S0165-5876(85)80011-2

10.1097/00003446-200010000-00011

10.1044/1058-0360(2001/009)

10.1097/01.inf.0000059764.77704.55

Browning GG, 2010, Grommets (ventilation tubes) for hearing loss associated with otitis media with effusion in children, Cochrane Database Syst Rev, 10

10.1136/adc.2004.059444

Maw AR, 1994, The long term outcome of secretory otitis media in children and the effects of surgical treatment: a ten year study, Acta Otorhinolaryngol Belg, 48, 317

American Speech‐Language‐Hearing Association.Directory of speech‐language pathology assessment onstruments.http://www.asha.org/assessments.aspx. Accessed March 24 2015.

American Speech‐Language‐Hearing Association.Typical speech and language development.http://www.asha.org/public/speech/development/. Accessed March 24 2015.

10.1044/jslhr.4304.821

Agency for Healthcare Research and Quality, 2015, Screening for Speech and Language Delay in Preschool Children

10.1044/jslhr.4203.744

10.1044/jshr.3605.948

10.1044/jshr.3301.70

10.1044/0161-1461(2005/031)

10.1044/0161-1461(2008/08-0009)

Glade M, 1996, Diagnostic and Therapeutic Technology Assessment: Speech Therapy in Patients with a Prior History of Recurrent Acute or Chronic Otitis Media with Effusion

10.1056/NEJMoa050406

10.1542/peds.106.3.e42

10.1097/00003446-200106000-00003

10.1097/00005537-200310000-00004

10.3109/00016488109133288

10.1016/j.ejps.2006.07.004

10.1001/archotol.1980.00790300033006

10.1001/archotol.1982.00790490006002

10.1007/BF00178987

10.1046/j.1365-2273.2001.00495.x

10.1001/archotol.1995.01890080033006

10.1016/j.cyto.2007.10.009

10.1016/j.ijporl.2014.12.015

Ru JA, 2004, Otitis media with effusion: disease or defense? A review of the literature, Int J Pediatr Otorhinolaryngol, 68, 331

10.1097/MLG.0b013e31816422d7

Maw AR, 1994, The long term outcome of secretory otitis media in children and the effects of surgical treatment: a ten year study, Acta Otorhinolaryngol Belg, 48, 317

10.1016/j.otohns.2004.02.002

Perera R, 2013, Autoinflation for hearing loss associated with otitis media with effusion, Cochrane Database Syst Rev, 5, CD006285

10.1097/00006454-199401001-00010

10.1136/adc.80.1.28

10.1136/adc.85.2.91

10.1044/jshd.5101.53

10.1097/00003446-199810000-00001

10.1136/adc.2004.059444

10.1177/0194599811409862

10.3310/hta18050

10.1001/jamaoto.2013.5842

10.1016/j.ijporl.2009.09.007

10.1542/peds.2004-2253

10.1213/ANE.0b013e318213be52

10.1067/mhn.2001.113941

10.1097/MAO.0b013e318254fbc2

10.1542/peds.2013-3228

10.1097/00005537-200405000-00014

Browning GG, 2010, Grommets (ventilation tubes) for hearing loss associated with otitis media with effusion in children, Cochrane Database Syst Rev, 10

10.1056/NEJM198712033172305

10.1001/jama.1990.03440150074029

10.1016/j.pec.2012.06.036

10.1001/archotol.1997.01900100019002

CalkinsC CoswayB CochranN VenkatramanG ElwynG.Option grid for fluid in the middle ear.http://www.optiongrid.org/resources/fluidinear_grid.pdf. Accessed March 3 2015.